文献速递冠心病心力衰竭与心肌病

年轻成人肾功能受损与主要心血管事件

Impaired Renal Function and Major Cardiovascular Events in Young Adults.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

BACKGROUND: Cardiovascular (CV) disease in young adults (aged 18-39 years) is on the rise. Whether subclinical reductions in kidney function (ie, estimated glomerular filtration rate [eGFR] above the current threshold for chronic kidney disease but below age-expected values) are …

要点

  • 年轻成人eGFR<80 mL/min/1.73 m2即与MACE风险升高相关
  • 18-30岁人群eGFR 70-79时MACE风险HR为1.31,高于年长组
  • 建议对年轻成人进行年龄适配的肾功能风险评估与监测

核心结论

  • 年轻成人eGFR低于年龄预期值与MACE及MACE+风险升高相关,需年龄适配的风险分层、主动监测和及时干预。

主要发现

  • 在平均年龄41.3岁、平均eGFR 104.2 mL/min/1.73 m2、中位随访9.2年的队列中,年轻成人eGFR<80 mL/min/1.73 m2时MACE和MACE+相对风险呈阶梯式升高。
  • 18-30岁人群eGFR 70-79 mL/min/1.73 m2时MACE发生率为2.37例/1000人年(HR 1.31;95% CI 1.27-1.40)。
  • 40-49岁人群eGFR 70-79 mL/min/1.73 m2时MACE发生率为6.26例/1000人年(HR 1.09;95% CI 1.06-1.12)。
  • 50-65岁人群eGFR 70-79 mL/min/1.73 m2时MACE发生率为14.9例/1000人年(HR 1.07;95% CI 1.05-1.08)。
  • 结果对每个MACE组分及额外分析(按既往心血管病分层、考虑基线白蛋白尿、使用重复eGFR测量)均稳健。

临床怎么用

  • 对年轻成人应关注eGFR低于年龄预期值的亚临床肾功能下降,将其纳入心血管风险分层。
  • 对eGFR<80 mL/min/1.73 m2的年轻成人可考虑主动监测和及时干预以降低MACE风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular (CV) disease in young adults (aged 18-39 years) is on the rise. Whether subclinical reductions in kidney function (ie, estimated glomerular filtration rate [eGFR] above the current threshold for chronic kidney disease but below age-expected values) are associated with elevated CV risk is unknown. OBJECTIVES: The goal of this study was to examine age-specific associations of subclinical eGFR reductions in young adults with major adverse cardiovascular events (MACEs) and MACE plus heart failure (MACE+). METHODS: A retrospective cohort study of 8.7 million individuals (3.6 million aged 18-39 years) was constructed using linked provincial health care data sets from Ontario, Canada (January 2008-March 2021). Cox models were used to examine the association of categorized eGFR (50-120 mL/min/1.73 m2) with MACE (first of CV mortality, acute coronary syndrome, and ischemic stroke) and MACE+, stratified according to age (18-39, 40-49, and 50-65 years). RESULTS: In the study cohort (mean age 41.3 years; mean eGFR 104.2 mL/min/1.73 m2; median follow-up 9.2 years), a stepwise increase in the relative risk of MACE and MACE+ was observed as early as eGFR <80 mL/min/1.73 m2 in young adults (eg, for MACE, at eGFR 70-79 mL/min/1.73 m2, ages 18-30 years: 2.37 events per 1,000 person years [HR: 1.31; 95% CI: 1.27-1.40]; ages 40-49 years: 6.26 events per 1,000 person years [HR: 1.09; 95% CI: 1.06-1.12]; ages 50-65 years: 14.9 events per 1,000 person years [HR: 1.07; 95% CI: 1.05-1.08]). Results persisted for each MACE component and in additional analyses (stratifying according to past CV disease, accounting for albuminuria at index, and using repeated eGFR measures). CONCLUSIONS: In young adults, eGFR below age-expected values were associated with an elevated risk for MACE and MACE+, warranting age-appropriate risk stratification, proactive monitoring, and timely intervention.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Hussain, Imsirovic, Canney, et al. Impaired Renal Function and Major Cardiovascular Events in Young Adults. J Am Coll Cardiol. 2023. PMID: 37730288. doi:10.1016/j.jacc.2023.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。